RECODE THERAPEUTICS
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
5
Funding Rounds
$298.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company RECODE THERAPEUTICS has raised a total of $215m in funding over 5 rounds.
Key Insights:
- ReCode Therapeutics November 2024 Venture - Series Unknown Funding Round: $15m
- RECODE THERAPEUTICS, INC. , June 2022: $120m
- RECODE THERAPEUTICS, INC. Funding Round, October 2021: $80m
- RECODE THERAPEUTICS, INC. funding round, March 2020: $80m
- RECODE THERAPEUTICS, INC. funding round, January 2017: $3m
ReCode Therapeutics November 2024 Venture - Series Unknown Funding Round
$15m
RECODE THERAPEUTICS, INC. , June 2022
$120m
RECODE THERAPEUTICS, INC. Funding Round, October 2021
$80m
RECODE THERAPEUTICS, INC. funding round, March 2020
$80m
RECODE THERAPEUTICS, INC. funding round, January 2017
$3m
Industries
RECODE THERAPEUTICS is active in the following industries:
- Biotechnology
- Technology
- Biology
- Genomics
- Genome editing
- Regenerative medicine
- Healthcare
- Tissue engineering
- Health technology
- Clean technology